Colesevelam hydrochloride

Details

Files

Generic Name:

Colesevelam hydrochloride

Project Status:

Complete

Therapeutic Area:

Hypercholesterolemia

Manufacturer:

Valeant Canada LP

Call for patient/clinician input open:

April 16, 2012

Brand Name:

Lodalis

Project Line:

Reimbursement Review

Project Number:

SR0274-000

Call for patient/clinician input closed:

May 22, 2012

NOC Status at Filing:

Post NOC

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Hypercholesterolemia

Recommendation Type:

Do not list at the submitted price

Final Recommendation:

December 19, 2012

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : April 27, 2012